Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017 (2017), Article ID 5372625, 7 pages
https://doi.org/10.1155/2017/5372625
Research Article

Serum ZAG Levels Were Associated with eGFR Mild Decrease in T2DM Patients with Diabetic Nephropathy

1Key Laboratory of Endocrinology of National Health and Family Planning Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China
2Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China
3Department of Endocrinology, Traditional Chinese Medicine Hospital of Muping District of Yantai City, Yantai, Shandong, China
4Department of Ophthalmology, Traditional Chinese Medicine Hospital of Muping District of Yantai City, Yantai, Shandong, China

Correspondence should be addressed to Fengying Gong

Received 24 September 2016; Revised 7 December 2016; Accepted 26 December 2016; Published 2 March 2017

Academic Editor: Kristin Eckardt

Copyright © 2017 Lingling Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. De Cosmo, C. Menzaghi, S. Prudente, and V. Trischitta, “Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence,” Nephrology, Dialysis, Transplantation, vol. 28, no. 1, pp. 29–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Qu, X. Zhou, G. Yang, L. Li, H. Liu, and Z. Liang, “The natural logarithm of zinc-α2-glycoprotein/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios,” Cytokine, vol. 79, no. 3, pp. 96–102, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Y. Gong, S. J. Zhang, J. Y. Deng et al., “Zinc-a2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue,” International Journal of Obesity, vol. 33, no. 9, pp. 1023–1030, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. T. Russell and M. J. Tisdale, “Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse,” International Journal of Obesity, vol. 35, no. 3, pp. 345–354, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. T. Russell and M. J. Tisdale, “Antidiabetic properties of zinc-alpha2-glycoprotein in ob/ob mice,” Endocrinology, vol. 151, no. 3, pp. 948–957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Balaz, M. Vician, Z. Janakova et al., “Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity,” Obesity, vol. 22, no. 8, pp. 1821–1829, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S. C. Lim, D. Q. Liying, W. C. Toy et al., “Adipocytokine zinc α2 glycoprotein (ZAG) as a novel urinary biomarker for normo-albuminuric diabetic nephropathy,” Diabetic Medicine, vol. 29, no. 7, pp. 945–949, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. V. Rao, X. Lu, M. Standley et al., “Proteomic identification of urinary biomarkers of diabetic nephropathy,” Diabetes Care, vol. 30, no. 3, pp. 629–637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. V. O. Leal, J. C. Lobo, M. B. Stockler-Pinto et al., “Is zinc-alpha2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis?” Clinica Chimica Acta, vol. 413, no. 5–6, pp. 616–619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Philipp, S. Kralisch, A. Bachmann et al., “Serum levels of the adipokine zinc-alpha2-glycoprotein are increased in chronic hemodialysis,” Metabolism, vol. 60, no. 5, pp. 669–672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. C. C. Pelletier, L. Koppe, P. M. Alix et al., “The relationship between renal function and plasma concentration of the cachectic factor zinc-alpha2-glycoprotein (ZAG) in adult patients with chronic kidney disease,” PloS One, vol. 9, no. 7, Article ID e103475, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. C. C. Pelletier, L. Koppe, M. L. Croze et al., “White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease,” Kidney International, vol. 83, no. 5, pp. 878–886, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. S. Lopez-Boado, I. Diez-Itza, J. Tolivia, and C. Lopez-Otin, “Glucocorticoids and androgens up-regulate the Zn-a2-glycoprotein messenger RNA in human breast cancer cells,” Breast Cancer Research and Treatment, vol. 29, no. 3, pp. 247–258, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Chalbos, D. Haagensen, T. Parish, and H. Rochefort, “Identification and androgen regulation of two proteins released by T47D human breast cancer cells,” Cancer Research, vol. 47, no. 11, pp. 2787–2792, 1987. View at Google Scholar
  15. S. T. Russell and M. J. Tisdale, “The role of glucocorticoids in the induction of zinca2-glycoprotein expression in adipose tissue in cancer cachexia,” British Journal of Cancer, vol. 92, no. 5, pp. 876–881, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Xu, W. Yu, P. Huang et al., “The age-specific association of waist circumference and risk of chronic kidney disease in patients with type 2 diabetes mellitus in Shandong, China,” International Journal of Endocrinology, vol. 2015, Article ID 715871, 6 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A. S. Levey, J. Coresh, E. Balk et al., “National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” Annals of Internal Medicine, vol. 139, no. 2, pp. 137–147, 2003. View at Publisher · View at Google Scholar
  18. C. J. Rosen, S. A. Abrams, J. F. Aloia et al., “IOM committee members respond to Endocrine Society vitamin D guideline,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1146–1152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Varghese, T. B. Powell, M. N. Budisavljevic et al., “Urine biomarkers predict the cause of glomerular disease,” Journal of the American Society of Nephrology, vol. 18, no. 3, pp. 913–922, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Jain, A. Rajput, Y. Kumar, N. Uppuluri, A. S. Arvind, and U. Tatu, “Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder,” The Journal of the Association of Physicians of India, vol. 53, no. 6, pp. 513–520, 2005. View at Google Scholar
  21. V. O. Leal, J. C. Lobo, M. B. Stockler-Pinto et al., “Zinc-a2-glycoprotein: is there association between this new adipokine and body composition in hemodialysis patients?” Renal Failure, vol. 34, no. 9, pp. 1062–1067, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Ekman, B. G. Johansson, and U. Ravnskov, “Renal handling of Zn-alpha2-glycoprotein as compared with that of albumin and the retinol-binding protein,” The Journal of Clinical Investigation, vol. 57, no. 4, pp. 945–954, 1976. View at Publisher · View at Google Scholar
  23. T. Gohda, Y. Makita, T. Shike et al., “Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a Type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity?” Diabetes, vol. 52, no. 8, pp. 2175–2181, 2003. View at Google Scholar
  24. D. M. Selva, A. Lecube, C. Hernández, J. A. Baena, J. M. Fort, and R. Simó, “Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 11, pp. 4499–4507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. H. J. Zhu, X. Q. Wang, H. Pan et al., “Serum levels of the adipokine zinc-α2-glycoprotein are decreased in patients with hypertension,” ISRN Endocrinology, vol. 9, no. 374090, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  26. H. J. Zhu, C. X. Dong, H. Pan et al., “rs4215 SNP in zinc-α2-glycoprotein gene is associated with obesity in Chinese north Han population,” Gene, vol. 500, no. 2, pp. 211–215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. D. C. Yeung, K. S. Lam, Y. Wang, A. W. Tso, and A. Xu, “Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 7, pp. 2531–2536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. E. Olofsson, B. Olsson, P. Jacobson et al., “Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids,” Metabolism, vol. 59, no. 9, pp. 1316–1318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Ceperuelo-Mallafré, X. Escoté, C. Viladés et al., “Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs,” HIV Medicine, vol. 13, no. 5, pp. 297–303, 2012. View at Google Scholar
  30. R. Rajpal, P. Dowling, J. Meiller et al., “A novel panel of protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patients,” Proteomics, vol. 11, no. 8, pp. 1391–1402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Wu, R. Shu, L. J. Luo, L. H. Ge, and Y. F. Xie, “Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects,” Journal of Periodontal Research, vol. 44, no. 5, pp. 636–644, 2009. View at Publisher · View at Google Scholar · View at Scopus